-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PRpE4FfWFBYlYxnaqOQcAz7XU0z114uUCdI7kr0NzwoCAlNEoxGEx1IPXohemRwl oABuowBzmNX8dCfGNNywuw== 0000901783-99-000003.txt : 19990215 0000901783-99-000003.hdr.sgml : 19990215 ACCESSION NUMBER: 0000901783-99-000003 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SIERRA HEALTH SERVICES INC CENTRAL INDEX KEY: 0000754009 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 880200415 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-38467 FILM NUMBER: 99533139 BUSINESS ADDRESS: STREET 1: 2724 N TENAYA WAY CITY: LAS VEGAS STATE: NV ZIP: 89128 BUSINESS PHONE: 7022427000 MAIL ADDRESS: STREET 1: 2724 NORTH TENAYA WAY STREET 2: 2724 NORTH TENAYA WAY CITY: LAS VEGAS STATE: NV ZIP: 89128 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MARLON ANTHONY M MD CENTRAL INDEX KEY: 0000901783 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 333 NORTH RANCHO DR CITY: LAS VEGAS STATE: NV ZIP: 89106 MAIL ADDRESS: STREET 1: PO BOX 15645 CITY: LAS VEGAS STATE: NV ZIP: 89114-5645 FORMER COMPANY: FORMER CONFORMED NAME: MARLON ANTHONY MD DATE OF NAME CHANGE: 19930422 SC 13G 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 11)* Sierra Health Services, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 826322-10-9 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. 826322-10-9 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Anthony M. Marlon, M.D. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) |_| (B) |_| - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America 5 SOLE VOTING POWER NUMBER OF 2,542,753 shares of Common Stock at 12/31/98 SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED BY -0- at 12/31/98 EACH REPORTING 7 SOLE DISPOSITIVE POWER PERSON 2,542,753 shares of Common Stock at 12/31/98 WITH 8 SHARED DISPOSITIVE POWER -0- at 12/31/98 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,542,753 shares of Common Stock at 12/31/98 - ------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |X| See Item 4 of attached Schedule 13G - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.3% of outstanding class at 12/31/98 - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - ------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Item 1. (a) Name of Issuer: Sierra Health Services, Inc. (b) Address of Issuer's Principal Executive Offices: 2724 North Tenaya Way Las Vegas, Nevada 89128 Item 2. (a) Name of Person Filing: Anthony M. Marlon, M.D. ("Dr. Marlon") (b) Address of Principal Business Office or, if none, Residence: 2724 North Tenaya Way Las Vegas, Nevada 89128 (c) Citizenship: United States of America (d) Title of Class of Securities: Common Stock, $.005 par value (e) CUSIP Number: 826322-10-9 Item 3. This statement is filed pursuant to Rule 13d-1(c). Items 3(a) through 3(h) are, therefore, inapplicable. Item 4. Ownership (a) Amount Beneficially Owned: Dr. Marlon may be deemed to beneficially own 2,542,753 shares of Common Stock at December 31, 1998. The number of shares reported as beneficially owned includes 2,329,003 shares held indirectly through a total of four trusts established by Dr. Marlon and his wife, and 1,500 shares held indirectly through a limited partnership (the "Partnership"). Dr. Marlon may be deemed to have or share voting power and/or dispositive power over the shares held by the four trusts and, therefore, to have beneficial ownership with respect to such shares. Dr. Marlon, as managing general partner of the Partnership, has sole voting and dispositive power over the shares held by the Partnership. Dr. Marlon disclaims beneficial ownership as to the shares held by the four trusts, other than the 1,135,341 shares held by the Marlon Family Trust (a revocable trust of which he is a trustee). The number of shares reported as beneficially owned also includes 212,250 shares that Dr. Marlon has a right to acquire within 60 days of December 31, 1998, upon exercise of options. Dr. Marlon's beneficial ownership does not include 163,054 shares held in three trusts for the benefit of family members, the trustee of each of which is Erin E. MacDonald, and does not include 652,648 shares held by the AMM & RM Family Limited Partnership, the general partner of which is a trust for the benefit of a family member; the trustees of that trust are Ms. MacDonald, William Godfrey, and Jeannine M. Zeller (daughter of Dr. Marlon). Dr. Marlon's beneficial ownership also does not include 102,750 shares subject to stock options which are not currently exercisable and will not become exercisable within 60 days after December 31, 1998. (b) Percent of Class: 9.3% of the class of Common Stock outstanding at December 31, 1998 (c) Number of shares as to which Dr. Marlon has: (i) sole power to vote or to direct the vote: 2,542,753 shares of Common Stock at December 31, 1998 (see Item 4(a) above.) (ii) shared power to vote or to direct the vote: -0- shares of Common Stock at December 31, 1998 (iii) sole power to dispose or to direct the disposition of: 2,542,753 shares of Common Stock at December 31, 1998 (see Item 4(a) above.) (iv) shared power to dispose or to direct the disposition of: -0- shares of Common Stock at December 31, 1998 Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification. Not applicable. This statement is filed pursuant to Rule 13d-1(c). The filing of this Amendment to Schedule 13G and amendments hereto, and the statements herein and therein, shall not be construed as an admission that any filing person or any other person named herein is, for purposes of Section 13(d), 13(g), 16(a), or 16(b) under the Exchange Act, or for any other purpose, the beneficial owner of any of the securities described herein or therein, except to the extent that a natural person is reported as having voting and dispositive power, and thus beneficial ownership for purposes of Sections 13(d) and 13(g), over securities owned directly by such person. SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 1999 Date /s/ Anthony M. Marlon, M.D. ANTHONY M. MARLON, M.D. Name/Title -----END PRIVACY-ENHANCED MESSAGE-----